NEW YORK, July 12 - Genaissance Pharmaceuticals announced Thursday that it identified an average of 14 different versions of every gene it examined in a recent study, which will appear in the July 20 issue of Science

The report unveils previously unknown variations in human genes, Genaissance CEO, Gualberto Ruano, said at a press conference on the study. Looking at 82 individuals from 4 different groups of diverse origin, the company identified 3,899 SNPs within 313 genes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.